News and Trends 30 Jan 2017 ‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier Ossianix, partnered with Lundbeck, is developing shark antibodies that can help therapeutics cross the blood brain barrier. Ossianix develops shark-inspired antibody fragments, VNARs, with outstanding properties thanks to their small size and high solubility. The company has now received a milestone payment from Danish pharma Lundbeck for the development of the technology as a delivery […] January 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jan 2017 The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge Cambridge’s image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there’s also an exciting entrepreneurial scene at the cutting edge of technology. We took a look at how big biotech is in the Silicon Fen. Cambridge’s Biotech cluster has an exemplary hive of talent, infrastructure, and capital – enough to create the same vibe […] January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
More News! 28 Jan 2017 Microbes Control the Massive Turbine Hall at London’s Tate Modern Philippe Parreno’s Anywhen, occupying the vast hall at Tate Modern, evolves over time in response to the control of tiny living beings. When you enter Tate Modern‘s vast Turbine Hall, you might see lights turning off and on and hear noises coming and going. Without an apparent pattern, sounds and light evolve while families take […] January 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 27 Jan 2017 Needle-free Treatments for Autoimmune Disorders from Switzerland It’s back to go back to the mainland. This week’s stop is in Hergiswill, a city by one of the many beautiful seas that can be found in Switzerland. There, the young biotech BioLingus is developing needle-free therapies for chronic diseases. City: Hergiswill, Switzerland Founded: 2014 Employees: 1-10 Financial data: N/A Mission: BioLingus develops non-invasive treatments for autoimmune and inflammatory […] January 27, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2017 Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6 clinical studies indicating that Adocia’s ultra-rapid insulin performs better than Eli Lilly’s Humalog, the big American pharma has decided to terminate its collaboration with the French biotech. As part of this […] January 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2017 Researchers are One Step Closer to Understanding Artificial Silk Silk is a material in high demand, and so is a method to produce it artificially. A Swedish-German team of researchers is studying how to make silk with milk whey protein. Besides making way for a potentially cheaper process, artificial silk could have important medical applications. Researchers from the Royal Institute of Technology (KTH) in Stockholm and […] January 27, 2017 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 2017 Europe’s Largest Biotech Actelion Seals the Deal with J&J for €28B Actelion will be acquired by J&J for a whopping €27.9B, and its early R&D pipeline will be spun out into a new Switzerland-based outfit. The wait is over folks: Actelion, the largest biotech in Europe and one of the only 9 to make it to the billion-euro club in 2016, has just announced its acquisition by Johnson & Johnson for a […] January 26, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jan 2017 Novartis Relies on Biotech to keep up its Solid Financial Performance Novartis has announced excellent results for 2016. Could its strong focus on biotech be the key to the big pharma’s success? Novartis just released its 2016 financial report, boasting €45.2B ($48.5B) in net sales and its therapeutic antibody for psoriasis, Cosentyx (secukinumab), becoming a blockbuster. The Swiss pharma is suffering competition from generics, but it expects […] January 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jan 2017 Update: From Lupus to a Vaccine for Diabetes Type I? Dates Announced Update (25/01/2016): NeoVacs has announced plans to obtain preclinical proof of concept in 2017 for its type 1 diabetes program and to initiate clinical development in the first half of 2018 with the recommendation of its Scientific Advisory Board. Published on 13/10/2016 Neovacs has announced a research collaboration that could lead to the development of […] January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jan 2017 Genetically Engineered Mosquitoes will arrive in India to fight Dengue Oxitec is preparing to start trials testing its solution to reduce the population of disease-transmitting insects in India with its own genetically modified mosquitoes. Oxitec, a spin-out from Oxford University, engineers mosquitoes to reduce their populations in areas where they spread infectious diseases. After success in Brazil and the Cayman Islands, the company is now heading […] January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jan 2017 Cryopreservation: Can you Cheat Death by Freezing Yourself? Some people have already decided to take a leap of faith by cryogenically freezing themselves, often in the attempt to beat a yet incurable disease. Is science ready for it? And are we? Cryopreservation is a fairly common practice in sci-fi cinema. Several film directors – from Stanley Kubrick in his masterpiece “2001: A Space […] January 25, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2017 Spanish Researchers Create a Human Skin 3D Printer Scientists in Spain have created a 3D printer that uses bioink to recreate authentic human skin for drug testing and regenerative medicine applications. Researchers from the Universidad Carlos III de Madrid (UC3) and collaborators, including the Spanish bioengineering firm BioDan, have presented a prototype of a 3D printer that can create completely functional human skin. An industrial model could […] January 24, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email